Dabigatran

This is a new anti-coagulant that has been shown to be as effective at stroke prevention in Atrial Fibrillation (AF) as Warfarin, but at reduced bleeding risk, and with no need for regular blood tests. It is a new agent, and in some patients, will not be tolerated. It still carries the risk of increased bleeding, compared to taking nothing, of course.


 

Related

Dabigatran